American Journal of Public Health, Vol 90, Issue 8 1241-1247, Copyright © 2000 by American Public Health Association

JOURNAL ARTICLE

A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group

JM Melse, ML Essink-Bot, PG Kramers and N Hoeymans
Department for Public Health Forecasting, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.

OBJECTIVES: This study estimated the burden of disease due to 48 major causes in the Netherlands in 1994 in disability-adjusted life-years (DALYs), using national epidemiologic data and disability weights, and explored associated problems and uncertainties. METHODS: We combined data from Dutch vital statistics, registrations, and surveys with Dutch disability weights to calculate disease-specific health loss in DALYs, which are the sum of years of life lost (YLLs) and years lived with disability (YLDs) weighted for severity. RESULTS: YLLs were primarily lost by cardiovascular diseases and cancers, while YLDs were mostly lost by mental disorders and a range of chronic somatic disorders (such as chronic nonspecific lung disease and diabetes). These 4 diagnostic groups caused approximately equal numbers of DALYs. Sensitivity analysis calls for improving the accuracy of the epidemiologic data in connection with disability weights, especially for mild and frequent diseases. CONCLUSIONS: The DALY approach appeared to be feasible at a national Western European level and produced interpretable results, comparable to results from the Global Burden of Disease Study for the Established Market Economies. Suggestions for improving the methodology and its applicability are presented.

This article has been cited by other articles:

				H. Dodhia and K. Phillips Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years J. Public Health Med., September 1, 2008; 30(3): 313 - 321. [Abstract] [Full Text] [PDF]

				A. Lapostolle, A. Lefranc, I. Gremy, and A. Spira Sensitivity analysis in summary measure of population health in France Eur J Public Health, April 1, 2008; 18(2): 195 - 200. [Abstract] [Full Text] [PDF]

				S. I. SAARNI, J. SUVISAARI, H. SINTONEN, S. PIRKOLA, S. KOSKINEN, A. AROMAA, and J. LONNQVIST Impact of psychiatric disorders on health-related quality of life: general population survey The British Journal of Psychiatry, April 1, 2007; 190(4): 326 - 332. [Abstract] [Full Text] [PDF]

				M. A.M. Jacobs-van der Bruggen, G. Bos, W. J. Bemelmans, R. T. Hoogenveen, S. M. Vijgen, and C. A. Baan Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk: Results from a modeling study Diabetes Care, January 1, 2007; 30(1): 128 - 134. [Abstract] [Full Text] [PDF]

				J. George, T. Vuong, M. J Bailey, D. C. Kong, J. L Marriott, and K. Stewart Development and Validation of the Medication-Based Disease Burden Index Ann. Pharmacother., April 1, 2006; 40(4): 645 - 650. [Abstract] [Full Text] [PDF]

				M. M. Ortegon, W. K. Redekop, and L. W. Niessen Cost-Effectiveness of Prevention and Treatment of the Diabetic Foot: A Markov analysis Diabetes Care, April 1, 2004; 27(4): 901 - 907. [Abstract] [Full Text] [PDF]

				G. ANDREWS, K. SANDERSON, J. CORRY, C. ISSAKIDIS, and H. LAPSLEY Cost-effectiveness of current and optimal treatment for schizophrenia The British Journal of Psychiatry, November 1, 2003; 183(5): 427 - 435. [Abstract] [Full Text] [PDF]

				D G Manuel, S E Schultz, and J A Kopec Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities Index J Epidemiol Community Health, November 1, 2002; 56(11): 843 - 850. [Abstract] [Full Text] [PDF]